Literature DB >> 2413171

Binding of lanthanum ions and ruthenium red to synaptosomes and its effects on neurotransmitter release.

R Tapia, C Arias, E Morales.   

Abstract

A technique for studying the binding of La3+ to synaptosomes in a double-beam spectrophotometer, using murexide as indicator, is described. The binding of La3+ was very rapid and Scatchard plots revealed two components, with KD values of 0.6 and 27 microM in a Na+-free medium (sucrose medium) and 2.3 and 63 microM in an ionic medium containing 135 mM Na+. The binding of the cationic dye ruthenium red (RuR) showed only one site, with a KD of 3.7 microM. La3+ binding was partially inhibited by RuR and vice versa, and La3+ was also capable of partially displacing RuR previously bound to the synaptosomes, particularly in the sucrose medium. The release of labeled gamma-aminobutyric acid (GABA) stimulated by K+ depolarization was inhibited by La3+ concentrations at or above 1 microM, in the ionic medium, whereas in the sucrose medium 2.5 microM or higher La3+ concentrations notably stimulated the spontaneous release of both GABA and glutamic acid. It is concluded that La3+ and RuR share at least one type of binding site, which is probably the high-affinity La3+ site. Since both La3+ and RuR at low concentrations have been shown to block the depolarization-induced Ca2+ entry in synaptosomes, this site might be related to the voltage-dependent Ca2+ entry involved in neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413171     DOI: 10.1111/j.1471-4159.1985.tb07213.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Influence of integrin-blocking peptide on gadolinium- and hypertonic shrinking-induced neurotransmitter release in rat brain synaptosomes.

Authors:  Tatyana V Waseem; Liudmila P Lapatsina; Sergei V Fedorovich
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

2.  Convulsions and wet-dog shakes produced by systemic or intrahippocampal administration of ruthenium red in the rat.

Authors:  G García-Ugalde; R Tapia
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

3.  Ruthenium red selectively inhibits oedema formation and increased blood flow induced by capsaicin in rabbit skin.

Authors:  T L Buckley; S D Brain; T J Williams
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

4.  Selective neurotoxicity of ruthenium red in primary cultures.

Authors:  I Velasco; J Morán; R Tapia
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

Review 5.  Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.

Authors:  Stephen J P Damment; Michael Pennick
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 6.  Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro.

Authors:  Michael St Pierre; Peter W Reeh; Katharina Zimmermann
Journal:  Exp Brain Res       Date:  2009-04-30       Impact factor: 1.972

7.  Enlargement and contracture of C2-ceramide channels.

Authors:  Leah J Siskind; Amirparviz Davoody; Naomi Lewin; Stephanie Marshall; Marco Colombini
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

8.  Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin.

Authors:  S Bevan; S Hothi; G Hughes; I F James; H P Rang; K Shah; C S Walpole; J C Yeats
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

9.  Lack of effect of sumatriptan and UK-14,304 on capsaicin-induced relaxation of guinea-pig isolated basilar artery.

Authors:  C T O'Shaughnessy; G J Waldron; H E Connor
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

10.  Effect of ruthenium red on responses mediated by activation of capsaicin-sensitive nerves of the rat urinary bladder.

Authors:  C A Maggi; S Giuliani; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.